Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILM OF LISINOPRIL USING NATURAL DISINTEGRANTS

Nikita Sanjay Chute*, Sachin B Dudhe

Maharashtra Institute of Pharmacy, Betala, Bramhapuri, Maharashtra

ABSTRACT

The formulation and evaluation of a fast-dissolving oral film of Lisinopril, a vital medication for hypertension treatment, were investigated in this study. A comprehensive preformulation study was conducted to characterize Lisinopril's physical and chemical properties, including organoleptic properties, solubility profile, infrared spectrum, loss on drying, melting point, and moisture content. Additionally, a calibration curve was established to quantify Lisinopril concentration accurately. Subsequently, various natural disintegrants were explored to optimize the formulation, considering parameters such as general appearance, thickness, weight, folding endurance, disintegrating time, tensile strength, moisture content, and assay. Among the formulations evaluated, F7 emerged as the optimized formulation, composed of Lisinopril, HPMC K4, HPMC K15, PEG-400, Xanthan gum, Mannitol, Citric acid, and DM water. The in-vitro release kinetics of formulation F7 revealed a diffusion-controlled release mechanism, with the Higuchi model providing the best fit. The study highlights the successful development of an optimized oral film formulation of Lisinopril, offering rapid drug dissolution and potential clinical benefits in hypertension management.

Keywords: Lisinopril, fast-dissolving oral film, natural disintegrants, optimization, in-vitro release kinetics.


[Full Text Article]